Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients: an observational study

6/12 Analysis of outcomes based on serum levels

Verschelden et al., medRxiv, doi:10.1101/2021.06.09.21258271 (Preprint)
Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients: an observational study

Source PDF Share Tweet

Prospective study of 139 hospitalized COVID-19 patients, showing 96% had zinc deficiency. Higher zinc levels were associated with a shorter length of hospitalization. Mortality and ventilation was lower with higher zinc levels, but not reaching statistical significance.

Verschelden et al., 6/12/2021, preprint, 8 authors.

All 31 studies All Outcomes

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit